APA

Rosenow F., Berkemeier A., Krug U., Müller-Tidow C., Gerss J., Silling G., Groth C., Wieacker P., Bogdanova N., Mesters R., Büchner T., Kienast J., Berdel W. E. & Stelljes M. (20140514). CD34(+) lineage specific donor cell chimerism for the diagnosis and treatment of impending relapse of AML or myelodysplastic syndrome after allo-SCT. : Bone marrow transplantation.

Chicago

Rosenow F, Berkemeier A, Krug U, Müller-Tidow C, Gerss J, Silling G, Groth C, Wieacker P, Bogdanova N, Mesters R, Büchner T, Kienast J, Berdel W E and Stelljes M. 20140514. CD34(+) lineage specific donor cell chimerism for the diagnosis and treatment of impending relapse of AML or myelodysplastic syndrome after allo-SCT. : Bone marrow transplantation.

Harvard

Rosenow F., Berkemeier A., Krug U., Müller-Tidow C., Gerss J., Silling G., Groth C., Wieacker P., Bogdanova N., Mesters R., Büchner T., Kienast J., Berdel W. E. and Stelljes M. (20140514). CD34(+) lineage specific donor cell chimerism for the diagnosis and treatment of impending relapse of AML or myelodysplastic syndrome after allo-SCT. : Bone marrow transplantation.

MLA

Rosenow F, Berkemeier A, Krug U, Müller-Tidow C, Gerss J, Silling G, Groth C, Wieacker P, Bogdanova N, Mesters R, Büchner T, Kienast J, Berdel W E and Stelljes M. CD34(+) lineage specific donor cell chimerism for the diagnosis and treatment of impending relapse of AML or myelodysplastic syndrome after allo-SCT. : Bone marrow transplantation. 20140514.